Since retromer-dependent glutamate receptor recycling has been shown to occur independent of APP [88], our previous and current results suggest that reduced SORL1 activity can, at least in principle, drive two key AD pathologies, amyloid pathology and synaptic pathology, through parallel mechanisms [84]. Here, SORL1 is linked to Alzheimer disease.